Intellia Therapeutics Inc (NASDAQ:NTLA)

54.03
Delayed Data
As of Jul 01
 +2.25 / +4.35%
Today’s Change
37.08
Today|||52-Week Range
180.59
-54.30%
Year-to-Date

Today’s Trading

Previous close51.76
Today’s open52.14
Day’s range51.36 - 54.82
Volume1,016,736
Average volume (3 months)1,260,707
Market cap$4.1B
Data as of 4:00pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)-57.61%
Earnings growth (this year)-52.43%
Earnings growth (next 5 years)+8.76%
Revenue growth (last year)-43.01%
P/E ratioNM
Price/Sales253.61
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
DNLIDenali Therapeutics ...+1.81+6.15%
----
ARWRArrowhead Pharmaceut...+0.75+2.13%
ZLABZai Lab Ltd+3.86+11.13%
Data as of 4:00pm ET, 07/01/2022

Financials

Next reporting dateAugust 4, 2022
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$33.1M
Annual profit (last year)-$267.9M
Net profit margin-810.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts